Valuation: Izotropic Corporation

Market Cap 9.48M 8.32M 7.86M 7.16M 13.41M 909M 13.5M 94.06M 36.43M 464M 35.61M 34.84M 1.49B P/E 2027 *
-
P/E 2028 * -
Enterprise Value 9.48M 8.32M 7.86M 7.16M 13.41M 909M 13.5M 94.06M 36.43M 464M 35.61M 34.84M 1.49B EV / Sales 2027 *
1.9x
EV / Sales 2028 * 0.95x
Free-Float
92.14%
Yield 2027 *
-
Yield 2028 * -
1 day-5.00%
1 week-15.56%
Current month-19.15%
1 month-17.39%
3 months-24.00%
6 months-17.39%
Current year-32.14%
1 week 0.18
Extreme 0.175
0.28
1 month 0.18
Extreme 0.175
0.28
Current year 0.18
Extreme 0.175
0.33
1 year 0.18
Extreme 0.175
0.49
3 years 0.04
Extreme 0.035
0.49
5 years 0.04
Extreme 0.035
1.24
10 years 0.04
Extreme 0.035
1.56
Manager TitleAgeSince
Chief Executive Officer 73 2023-05-31
Director of Finance/CFO 75 2022-12-31
Chief Operating Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 73 2016-05-18
Director/Board Member 51 2017-05-21
Director/Board Member 71 2017-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/18/25 Option

Chief Financial Officer

100,000 0.1761%
9/18/25 Option

Chief Financial Officer

100,000 0.1761%
9/17/25 Sell

Chief Financial Officer

100,000 0.1761%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-15.56%-52.50%-13.64% 9.48M
+0.21%+1.40%-29.04%-1.20% 12.47B
-7.14%-2.36%+9.78%+10.44% 4.16B
-2.48%+1.37%-43.34%-61.00% 1.21B
+0.66%+4.43%+22.04%+97.92% 1.1B
-0.57%+3.04%-40.83%-42.55% 1.09B
-1.58%+1.70%-34.49% - 1.03B
-3.18%-0.52% - - 996M
-2.64%-4.46%+29.60%+97.40% 494M
+7.78%-0.75%+45.20% - 333M
Average -1.39%-1.17%-10.40%+12.48% 2.29B
Weighted average by Cap. -1.46%+0.70%-18.31%+3.09%

Financials

2027 *2028 *
Net sales 5M 4.39M 4.14M 3.78M 7.07M 479M 7.12M 49.59M 19.21M 245M 18.77M 18.37M 787M 10M 8.77M 8.29M 7.55M 14.14M 958M 14.24M 99.17M 38.41M 490M 37.55M 36.73M 1.57B
Net income 2.3M 2.02M 1.91M 1.74M 3.25M 221M 3.28M 22.82M 8.84M 113M 8.64M 8.45M 362M 6.23M 5.47M 5.16M 4.7M 8.81M 597M 8.87M 61.77M 23.92M 305M 23.38M 22.88M 980M
Net Debt - -
Logo Izotropic Corporation
Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.
Employees
-
Date Price Change Volume
26-09-25 $0.1900 -5.00% 129,086
26-09-24 $0.2000 -4.76% 2,501
26-09-23 $0.2100 +10.53% 800
26-09-21 $0.1900 -15.56% 26,349
26-09-18 $0.2250 +18.42% 5,000

Quarterly revenue - Rate of surprise